Thanks to the growing need for personalised healthcare. The next-generation sequencing (NGS) data analysis market is projected to reach $4.21b by 2032 at a compound annual growth rate of approximately ...

NGS enables the in-depth analysis of the genome and the identification and investigation of disease-associated variants–especially when workflows include target enrichment, which focuses on specific ...